Absci, a biotech company, is revolutionizing drug discovery by leveraging the power of generative AI. By combining biology and AI, Absci is creating drugs at an unprecedented speed. Their innovative approach has been featured in Nasdaq Biotech Spotlight and WSJ Tech Live 2022. Join Absci in unlocking the full potential of AI to develop better treatments for patients worldwide.